Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05116> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05116 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05116 label "NB1011 [drugbank:DB05116]" assertion.
- drugbank:DB05116 seeAlso DB05116 assertion.
- drugbank:DB05116 identifier "drugbank:DB05116" assertion.
- drugbank:DB05116 description "NB1011, a phosphoramidate derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine, is a novel small molecule anticancer agent. NB1011 is selectively active against tumor cells expressing high levels of thymidylate synthase (TS), a critical enzyme in DNA biosynthesis. NB1011 was as efficacious as irinotecan, a drug recently approved for the treatment of 5-fluorouracil-resistant colon cancer." assertion.
- drugbank:DB05116 title "NB1011" assertion.
- drugbank:DB05116 bio2rdf_vocabulary:identifier "DB05116" assertion.
- drugbank:DB05116 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05116 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05116" assertion.
- drugbank:DB05116 bio2rdf_vocabulary:x-identifiers.org DB05116 assertion.
- drugbank:DB05116 drugbank_vocabulary:drugbank-id "DB05116" assertion.
- drugbank:DB05116 drugbank_vocabulary:x-cas cas:232925-18-7 assertion.